Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 137

1.

Opinion: To curate the molecular past, museums need a carefully considered set of best practices.

Austin RM, Sholts SB, Williams L, Kistler L, Hofman CA.

Proc Natl Acad Sci U S A. 2019 Jan 29;116(5):1471-1474. doi: 10.1073/pnas.1822038116. No abstract available.

2.

Application of Bayesian network modeling to pathology informatics.

Onisko A, Druzdzel MJ, Austin RM.

Diagn Cytopathol. 2019 Jan;47(1):41-47. doi: 10.1002/dc.23993. Epub 2018 Nov 19.

PMID:
30451397
3.

Enhanced Detection of Cervical Cancer and Precancer Through Use of Imaged Liquid-Based Cytology in Routine Cytology and HPV Cotesting.

Austin RM, Onisko A, Zhao C.

Am J Clin Pathol. 2018 Oct 1;150(5):385-392. doi: 10.1093/ajcp/aqy114.

PMID:
30137189
4.

Quality Improvement to Demonstrate the Lack of Reliability of the Human Papillomavirus mRNA Assay to Identify Women With Latent Human Papillomavirus Infections.

Austin RM, Zhao C, Mody DR.

Obstet Gynecol. 2018 Sep;132(3):777. doi: 10.1097/AOG.0000000000002824. No abstract available.

PMID:
30134392
5.

Use of Uterine Characteristics to Improve Fertility-Sparing Diagnosis of Adenomyosis.

Ecker AM, Chamsy D, Austin RM, Guido RS, Lee TTM, Mansuria SM, Rindos NB, Donnellan NM.

J Gynecol Surg. 2018 Aug 1;34(4):183-189. doi: 10.1089/gyn.2017.0112.

PMID:
30087549
6.

Digital Applications in Cytopathology: Problems, Rationalizations, and Alternative Approaches.

Chantziantoniou N, Mukherjee M, Donnelly AD, Pantanowitz L, Austin RM.

Acta Cytol. 2018;62(1):68-76. doi: 10.1159/000484434. Epub 2017 Nov 29.

PMID:
29183021
7.

Histopathologic follow-up and HPV test results with HSIL Papanicolaou test results in China's largest academic women's hospital.

Tao X, Austin RM, Zhang H, Zhang L, Xiao J, Zhou X, Wang L, Zhao C.

Cancer Cytopathol. 2017 Dec;125(12):947-953. doi: 10.1002/cncy.21914. Epub 2017 Sep 8.

8.

Negative Predictive Value and Significance of Benign-Appearing Endometrial Cells in Papanicolaou Tests.

Yu J, Onisko A, Austin RM.

Am J Clin Pathol. 2017 Sep 1;148(3):274-279. doi: 10.1093/AJCP/AQX075.

PMID:
28821196
9.

George Papanicolaou's Efforts to Develop Novel Cytologic Methods for the Early Diagnosis of Endometrial Carcinoma.

Austin RM.

Acta Cytol. 2017;61(4-5):281-298. doi: 10.1159/000475980. Epub 2017 Jul 11. Review.

10.

Inception and Development of the Papanicolaou Stain Method.

Chantziantoniou N, Donnelly AD, Mukherjee M, Boon ME, Austin RM.

Acta Cytol. 2017;61(4-5):266-280. doi: 10.1159/000457827. Epub 2017 Apr 7. Review.

11.

How to interpret the results of medical time series data analysis: Classical statistical approaches versus dynamic Bayesian network modeling.

Onisko A, Druzdzel MJ, Austin RM.

J Pathol Inform. 2016 Dec 30;7:50. doi: 10.4103/2153-3539.197191. eCollection 2016.

12.

Vaginal Cytology Results in Follow-up of Endometrial Carcinoma After Hysterectomy.

Zhao C, Karunamurthy A, Jain S, Austin RM.

Am J Clin Pathol. 2016 Aug;146(2):244-7. doi: 10.1093/ajcp/aqw100. Epub 2016 Jun 30.

PMID:
27371362
13.

HPV test results provide useful risk stratification information in women with ASC-H Pap test findings.

Austin RM, Zhao C.

Cancer Cytopathol. 2016 Oct;124(10):754. doi: 10.1002/cncy.21755. Epub 2016 Jun 23. No abstract available.

14.

Significance of Human Papillomavirus Test Performance in Samples From Women With Histopathologically Confirmed Invasive Cervical Cancer.

Austin RM, Olawaiye AB, Zhao C.

J Low Genit Tract Dis. 2016 Jul;20(3):e52. doi: 10.1097/LGT.0000000000000218. No abstract available.

PMID:
27137506
15.

Follow-up of Women With Negative Pap Test Results and Abnormal Clinical Signs or Symptoms.

Ocque R, Austin RM.

Am J Clin Pathol. 2016 Apr;145(4):560-7. doi: 10.1093/ajcp/aqw040. Epub 2016 Apr 22.

PMID:
27124948
16.

Prevalence of High-Risk Human Papillomavirus Infection in China: ‚ÄČAnalysis of 671,163 Human Papillomavirus Test Results From China's Largest College of American Pathologists-Certified Laboratory.

Zeng Z, Austin RM, He X, Chen X, Guo X, Zheng B, Wu S, Yang H, Zhao C.

Am J Clin Pathol. 2016 May;145(5):622-5. doi: 10.1093/ajcp/aqw010. Epub 2016 Mar 2.

PMID:
27124932
17.

Pap Test Reporting Rates for Conventional Smear and Liquid-Based Cervical Cytology from the Largest Academic Women's Hospital in China: Analysis of 1,248,785 Pap Test Reports.

Tao X, Austin RM, Zhang H, Zhang L, Xiao J, Wang L, Zhou X, Zhao C.

Acta Cytol. 2015;59(6):445-51. doi: 10.1159/000443679. Epub 2016 Jan 21.

PMID:
26789332
18.
19.

HPV primary screening: unanswered questions.

Austin RM.

Cytopathology. 2016 Feb;27(1):73-4. doi: 10.1111/cyt.12279. Epub 2015 Nov 24. No abstract available.

PMID:
26597328
20.

The Role of High-Risk Human Papilloma Virus Testing in the Surveillance of Cervical Cancer After Treatment.

Yu MC, Austin RM, Lin J, Beck T, Beriwal S, Comerci JT, Edwards RP, Sukumvanich P, Kelley J, Olawaiye AB.

Arch Pathol Lab Med. 2015 Nov;139(11):1437-40. doi: 10.5858/arpa.2014-0534-OA.

PMID:
26516940
21.

Reply to Comparison of cervical cancer screening results among 256,648 women in multiple clinical practices.

Rabin DS, Blatt AJ, Kennedy R, Luff RD, Austin RM.

Cancer Cytopathol. 2015 Sep;123(9):566-7. doi: 10.1002/cncy.21570. Epub 2015 Jul 15. No abstract available.

22.
23.

Comparison of cervical cancer screening results among 256,648 women in multiple clinical practices.

Blatt AJ, Kennedy R, Luff RD, Austin RM, Rabin DS.

Cancer Cytopathol. 2015 May;123(5):282-8. doi: 10.1002/cncy.21544. Epub 2015 Apr 10. Erratum in: Cancer Cytopathol. 2016 May;124(5):362-3.

24.

Follow-up outcomes in a large cohort of patients with HPV-negative LSIL cervical screening test results.

Barron S, Austin RM, Li Z, Zhao C.

Am J Clin Pathol. 2015 Apr;143(4):485-91. doi: 10.1309/AJCPU57UELKUZCYY.

PMID:
25779999
25.
26.

Is 58% sensitivity for detection of cervical intraepithelial neoplasia 3 and invasive cervical cancer optimal for cervical screening?

Austin RM, Zhao C.

Cytojournal. 2014 May 22;11:14. doi: 10.4103/1742-6413.132997. eCollection 2014. Review.

27.

Brush cytology of the fallopian tube and implications in ovarian cancer screening.

Lum D, Guido R, Rodriguez E, Lee T, Mansuria S, D'Ambrosio L, Austin RM.

J Minim Invasive Gynecol. 2014 Sep-Oct;21(5):851-6. doi: 10.1016/j.jmig.2014.03.017. Epub 2014 Apr 5.

PMID:
24713115
28.

Ultrasound Guided Core Biopsy versus Fine Needle Aspiration for Evaluation of Axillary Lymphadenopathy in Patients with Breast Cancer.

Ganott MA, Zuley ML, Abrams GS, Lu AH, Kelly AE, Sumkin JH, Chivukula M, Carter G, Austin RM, Bandos AI.

ISRN Oncol. 2014 Feb 4;2014:703160. doi: 10.1155/2014/703160. eCollection 2014.

30.

Cytologic findings in experimental in vivo fallopian tube brush specimens.

Rodriguez EF, Lum D, Guido R, Austin RM.

Acta Cytol. 2013;57(6):611-8. doi: 10.1159/000353825. Epub 2013 Oct 1.

31.

Abdominopelvic washings: A comprehensive review.

Rodriguez EF, Monaco SE, Khalbuss W, Austin RM, Pantanowitz L.

Cytojournal. 2013 Apr 24;10:7. doi: 10.4103/1742-6413.111080. Print 2013.

32.

Cervical screening test results associated with 265 histopathologic diagnoses of cervical glandular neoplasia.

Zhao C, Li Z, Austin RM.

Am J Clin Pathol. 2013 Jul;140(1):47-54. doi: 10.1309/AJCPIP9M8HPVBSSC.

PMID:
23765533
34.

Follow-up outcomes of a large cohort of low-risk women with negative imaged liquid-based cytology and negative HPV test results.

Zhao C, Weng B, Li Z, Yang H, Austin RM.

Am J Clin Pathol. 2013 Jan;139(1):32-8. doi: 10.1309/AJCP4DF7ACLBFFGY.

PMID:
23270896
35.

Limitations of widely used high-risk human papillomavirus laboratory-developed testing in cervical cancer screening.

Naryshkin S, Austin RM.

Drug Healthc Patient Saf. 2012;4:167-72. doi: 10.2147/DHPS.S37273. Epub 2012 Nov 2.

36.

Cytology and human papillomavirus screening test results associated with 2827 histopathologic diagnoses of cervical intraepithelial neoplasia 2/3.

Zhao C, Amin M, Weng B, Chen X, Kanbour-Shakir A, Austin RM.

Arch Pathol Lab Med. 2013 Jul;137(7):942-7. doi: 10.5858/arpa.2012-0307-OA. Epub 2012 Oct 10.

PMID:
23050808
37.

Follow-up outcomes in a large cohort of patients with human papillomavirus-negative ASC-H cervical screening test results.

Cohen D, Austin RM, Gilbert C, Freij R, Zhao C.

Am J Clin Pathol. 2012 Oct;138(4):517-23.

PMID:
23010706
38.

Screening test results associated with cancer diagnoses in 287 women with cervical squamous cell carcinoma.

Li Z, Austin RM, Guo M, Zhao C.

Arch Pathol Lab Med. 2012 Dec;136(12):1533-40. doi: 10.5858/arpa.2011-0609-OA. Epub 2012 Aug 20.

PMID:
22900617
39.

Heavy cervical cancer burden in elderly women: how can we improve the situation?

Skaznik-Wikiel ME, Sukumvanich P, Austin RM, Zorn KK, Krivak TC, Edwards RP, Olawaiye AB.

Acta Cytol. 2012;56(4):388-93. doi: 10.1159/000338555. Epub 2012 Jul 25.

PMID:
22846717
40.

ATHENA trial CIN 2+ cervical biopsy misclassifications raise questions.

Austin RM.

Am J Clin Pathol. 2012 Jun;137(6):1012. doi: 10.1309/AJCPMRVTJ8IP1LWH. No abstract available.

PMID:
22586060
41.

American Society of Cytopathology workload recommendations for automated Pap test screening: developed by the productivity and quality assurance in the era of automated screening task force.

Elsheikh TM, Austin RM, Chhieng DF, Miller FS, Moriarty AT, Renshaw AA; American Society of Cytopathology.

Diagn Cytopathol. 2013 Feb;41(2):174-8. doi: 10.1002/dc.22817. Epub 2012 Feb 20.

PMID:
22351120
42.

Type 1 and type 2 cervical carcinomas: some cervical cancers are more difficult to prevent with screening.

Austin RM, Zhao C.

Cytopathology. 2012 Feb;23(1):6-12. doi: 10.1111/j.1365-2303.2011.00955.x. Review.

PMID:
22243288
43.

Histopathologic outcomes and clinical correlations for high-risk patients screened with anal cytology.

Zhao C, Domfeh AB, Austin RM.

Acta Cytol. 2012;56(1):62-7. doi: 10.1159/000331431. Epub 2012 Jan 4.

PMID:
22236747
44.

Correlation of histopathologic follow-up findings with vaginal human papillomavirus and low-grade squamous intraepithelial lesion Papanicolaou test results.

Bansal M, Austin RM, Zhao C.

Arch Pathol Lab Med. 2011 Dec;135(12):1545-9. doi: 10.5858/arpa.2010-0658-OA.

PMID:
22129181
45.

Unrecognized risks associated with new cervical screening guidelines for younger women.

Austin RM, Zhao C.

Arch Pathol Lab Med. 2011 Sep;135(9):1080. doi: 10.5858/2011-0209-LE.1. No abstract available.

PMID:
21877988
46.

Histopathologic follow-up and human papillomavirus DNA test results in 290 patients with high-grade squamous intraepithelial lesion Papanicolaou test results.

Gao FF, Austin RM, Zhao C.

Cancer Cytopathol. 2011 Dec 25;119(6):377-86. doi: 10.1002/cncy.20176. Epub 2011 Jul 19.

47.

Cultured neonatal rat cardiomyocytes display differences in glucose uptake and sensitivity to dexamethasone related to maternal diet.

Austin RM, Langley-Evans SC.

J Dev Orig Health Dis. 2011 Jun;2(3):190-4. doi: 10.1017/S2040174411000183.

PMID:
25141045
48.

Follow-up outcomes for a large cohort of US women with negative imaged liquid-based cytology findings and positive high risk human papillomavirus test results.

Zhao C, Chen X, Onisko A, Kanbour A, Austin RM.

Gynecol Oncol. 2011 Aug;122(2):291-6. doi: 10.1016/j.ygyno.2011.04.037. Epub 2011 May 23.

PMID:
21601911
49.

Cytomorphology of crystal storing histiocytosis in the breast associated with lymphoma: a case report.

Gao FF, Khalbuss WE, Austin RM, Monaco SE.

Acta Cytol. 2011;55(3):302-6. doi: 10.1159/000324558. Epub 2011 Apr 27.

PMID:
21525745
50.

Follow-up findings in young females with high-grade squamous intraepithelial lesion papanicolaou test results.

Zhao C, Kalposi-Novak P, Austin RM.

Arch Pathol Lab Med. 2011 Mar;135(3):361-4. doi: 10.1043/2010-0121-OA.1.

PMID:
21366461

Supplemental Content

Loading ...
Support Center